Siemens Files PMA For Digital Breast Tomosynthesis

Published: Jun 27, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MALVERN, Pa.--(BUSINESS WIRE)--Siemens Healthcare has announced that it recently submitted to the U.S. Food and Drug Administration (FDA) its premarket approval application (PMA) for the MAMMOMAT Inspiration® with Breast Tomosynthesis option.

Help employers find you! Check out all the jobs and post your resume.

Back to news